Trinity Biotech plc (TRIB)
Nasdaq: TRIB · In Vitro & In Vivo Diagnostic Substances · filing with the SEC since 1996
Who runs Trinity Biotech plc
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedOfficers reporting now
1
of 5 people with a filing in the last fifteen months
Directors reporting now
4
5 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Murphy Paul | Interim CFO | Apr 2026 | Apr 3, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Gillard John | director | Apr 2026 | Apr 8, 2026 | none |
| O'Caoimh Ronan | director | Apr 2026 | Apr 8, 2026 | none |
| Omidvar Andrew | director | Apr 2026 | Apr 3, 2026 | none |
| Tivnan John Paul | director | Apr 2026 | Apr 3, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.